A novel epigenetic signature for overall survival prediction in patients with breast cancer

BACKGROUND: Breast cancer is the most common malignancy in female patients worldwide. Because of its heterogeneity in terms of prognosis and therapeutic response, biomarkers with the potential to predict survival or assist in making treatment decisions in breast cancer patients are essential for an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Xuanwen, Anastasov, Natasa, Wang, Yanfang, Rosemann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889649/
https://www.ncbi.nlm.nih.gov/pubmed/31747912
http://dx.doi.org/10.1186/s12967-019-2126-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889649/
https://www.ncbi.nlm.nih.gov/pubmed/31747912
http://dx.doi.org/10.1186/s12967-019-2126-6

Ejemplares similares